Works matching IS 0195668X AND DT 2019 AND VI 40 AND IP 19

Results: 25

Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1518, doi. 10.1093/eurheartj/ehy807

By:

Chao, Tze-Fan;
Chen, Shih-Ann;
Ruff, Christian T;
Hamershock, Rose A;
Mercuri, Michele F;
Antman, Elliott M;
Braunwald, Eugene;
Giugliano, Robert P

Publication type:

Article

Challenges in clinical decision-making on concomitant drug therapies in patients with atrial fibrillation taking oral anticoagulants.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1569, doi. 10.1093/eurheartj/ehy784

By:

Steffel, Jan;
Potpara, Tatjana S

Publication type:

Article

Cardiac tamponade after pulmonary endarterectomy: mind the left side.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1575, doi. 10.1093/eurheartj/ehy785

By:

Bibas, Lior;
Al-Kalbani, Moza;
Perrot, Marc de;
Douflé, Ghislaine

Publication type:

Article

Breaking Down the Hierarchy of Medicine: The airline industry has taken the lead to improve communications for pilots, it is now time for medicine to follow with physicians.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1482, doi. 10.1093/eurheartj/ehz264

By:

Panhwar, Muhammad Siyab;
Kalra, Ankur

Publication type:

Article

Biomarkers and Cardiovascular Risk Stratification: Extensive research reports that biomarkers may be helpful in the assessment of thromboembolic and bleeding risk in patients with atrial fibrillation. At the same time, increasing evidence suggests their role in personalized medicine and in prediction of clinical outcomes in heart failure

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1483, doi. 10.1093/eurheartj/ehz265

By:

Matusik, Paweł T

Publication type:

Article

Atrial fibrillation, with ACS and PCI: walking a tightrope.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1563, doi. 10.1093/eurheartj/ehz192

By:

Mehran, Roxana;
Kalkman, Deborah N;
Angiolillo, Dominick J

Publication type:

Article

Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1504, doi. 10.1093/eurheartj/ehy837

By:

Chao, Tze-Fan;
Lip, Gregory Y H;
Lin, Yenn-Jiang;
Chang, Shih-Lin;
Lo, Li-Wei;
Hu, Yu-Feng;
Tuan, Ta-Chuan;
Liao, Jo-Nan;
Chung, Fa-Po;
Chen, Tzeng-Ji;
Chen, Shih-Ann

Publication type:

Article

When is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation? A multicentre prospective randomized study.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1531, doi. 10.1093/eurheartj/ehy870

By:

Yu, Hee Tae;
Shim, Jaemin;
Park, Junbeom;
Kim, Tae-Hoon;
Uhm, Jae-Sun;
Kim, Jong-Youn;
Joung, Boyoung;
Lee, Moon-Hyoung;
Kim, Young-Hoon;
Pak, Hui-Nam

Publication type:

Article

Unresolved issues of anticoagulation in atrial fibrillation: age, BMI, reduced dose, and ethnicity.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1477, doi. 10.1093/eurheartj/ehz302

By:

Lüscher, Thomas F

Publication type:

Article

rare case of percutaneous exclusion of a huge aortic pseudo-aneurysm following aortic bio prosthetic endocarditis: key role of 3D echo-fluoro fusion imaging.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1573, doi. 10.1093/eurheartj/ehy916

By:

Gavazzoni, Mara;
Pozzoli, Alberto;
Mestres, Carlos A;
Maisano, Francesco

Publication type:

Article

Saving the brain from catheter ablation of atrial fibrillation: the role of pre- and peri-procedural anticoagulation.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1538, doi. 10.1093/eurheartj/ehz017

By:

Bunch, Jared T;
Woller, Scott C

Publication type:

Article

Reply to letter by Bamford et al. regarding the article: Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1568, doi. 10.1093/eurheartj/ehy743

By:

Piccini, Jonathan P;
Garg, Jyotsna;
Hellkamp, Anne;
Pieper, Karen S;
Patel, Manesh R

Publication type:

Article

Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1541, doi. 10.1093/eurheartj/ehy861

By:

Boriani, Giuseppe;
Ruff, Christian T;
Kuder, Julia F;
Shi, Minggao;
Lanz, Hans J;
Rutman, Howard;
Mercuri, Michele F;
Antman, Elliott M;
Braunwald, Eugene;
Giugliano, Robert P

Publication type:

Article

Acute Coronary Syndromes in Cancer Patients: The differences of ACS in cancer patients and the general population are discussed.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1487, doi. 10.1093/eurheartj/ehz267

By:

Guha, Avirup;
Dey, Amit K;
Jneid, Hani;
Addison, Daniel

Publication type:

Article

Stroke prevention in AF: Of Asians and non-Asians.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1528, doi. 10.1093/eurheartj/ehy776

By:

Steffel, Jan;
Eikelboom, John W

Publication type:

Article

On-label reduced doses of non-vitamin K anticoagulants prove safe and efficient; yet how to ensure the correct dose for the right patient?

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1501, doi. 10.1093/eurheartj/ehz014

By:

Atar, Dan;
Grundvold, Irene

Publication type:

Article

Impact of the New ACC/AHA and ESC/ESH Hypertension Guidelines for Norway.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1485, doi. 10.1093/eurheartj/ehz266

By:

Kjeldsen, Sverre E;
AKSNES, Tonje Amb;
MO, Rune;
KLEMSDAL, Tor Ole

Publication type:

Article

Fine-tuning the decision to initiate anticoagulation in atrial fibrillation by accounting for age and cardiovascular comorbidities.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1515, doi. 10.1093/eurheartj/ehz004

By:

Goldhaber, Samuel Z;
Piazza, Gregory

Publication type:

Article

evolving obesity paradigm story: from heart failure to atrial fibrillation.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1550, doi. 10.1093/eurheartj/ehz082

By:

Haehling, Stephan von;
Doehner, Wolfram;
Anker, Stefan D

Publication type:

Article

Where's the bleed? A response to Piccini et al.'s: Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1567, doi. 10.1093/eurheartj/ehy739

By:

Bamford, Paul;
Rogers, James

Publication type:

Article

Drug–drug interaction between levetiracetam and non-vitamin K antagonist anticoagulants.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1571, doi. 10.1093/eurheartj/ehy780

By:

Mathy, François-Xavier;
Dohin, Elisabeth;
Bonfitto, François;
Pelgrims, Barbara

Publication type:

Article

Dr Aram J. Mirza and cardiology in Kurdistan: First TAVI at the Slemani Cardiac Hospital in Kurdistan and a vision towards a Center of excellence in cardiovascular medicine in Kurdistan, Iraq and the Middle-East.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1490, doi. 10.1093/eurheartj/ehz268

By:

Frangieh, Antonio H

Publication type:

Article

Combination of non-vitamin K antagonist oral anticoagulants and antiepileptic drugs.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1572, doi. 10.1093/eurheartj/ehz091

By:

Kurt, Semiha;
Sumbul, Orhan;
Aksoy, Durdane

Publication type:

Article

Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1492, doi. 10.1093/eurheartj/ehy802

By:

Wang, Kang-Ling;
Lopes, Renato D;
Patel, Manesh R;
Büller, Harry R;
Tan, Doreen Su-Yin;
Chiang, Chern-En;
Giugliano, Robert P

Publication type:

Article

Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.

Published in:

European Heart Journal, 2019, v. 40, n. 19, p. 1553, doi. 10.1093/eurheartj/ehz059

By:

Oldgren, Jonas;
Steg, Philippe Gabriel;
Hohnloser, Stefan H;
Lip, Gregory Y H;
Kimura, Takeshi;
Nordaby, Matias;
Brueckmann, Martina;
Kleine, Eva;
Berg, Jurrien M ten;
Bhatt, Deepak L;
Cannon, Christopher P

Publication type:

Article